The present disclosure relates to compounds that are capable of inhibiting the ENPP1 gene and treating a variety of cardiac conditions. The disclosure further relates to methods of treating or preventing cardiac conditions, such as myocardial infarction and heart failure.
-
Page/Page column 29-30
(2022/04/03)
More Articles about upstream products of 462068-03-7